lobbying_activities: 3194792

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3194792	b088f369-911e-4fc6-ac2e-ce76ea191684	Q2	BURRELL INTERNATIONAL GROUP LLC	401103483	TONIX PHARMACEUTICALS HOLDING CORP.	2024	second_quarter	PHA	LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products; FY25 Defense Appropriation for broad-spectrum antivirals, FY25 LHHS for long covid and cocaine overdose funding	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2024-07-16T16:30:38-04:00